Company Filing History:
Years Active: 2017-2025
Title: **Sang Keun Woo: Innovator in Radiopharmaceutical Technologies**
Introduction
Sang Keun Woo is an esteemed inventor based in Seoul, South Korea, known for his significant contributions to the field of radiopharmaceuticals. With a remarkable portfolio that includes two patents, Sang Keun Woo has made considerable strides in advancing medical imaging technologies.
Latest Patents
Sang Keun Woo's latest innovations focus on enhancing radiopharmaceutical imaging methods using deep learning techniques. His first patent, titled "Radiopharmaceutical distribution image generation system and method using deep learning," pertains to generating spatial distribution images of radiopharmaceuticals from static medical images. This approach allows dynamic medical images collected from multiple patients to be analyzed and improves the ability to perform quantitative analysis based on time-radiation dose distribution curves.
Additionally, his other patent, "Apparatus and method of resampling event data for quantitative improvement of pet image," addresses the challenges associated with improving the quality of PET images. This invention revolves around analyzing the storage format of list data and implementing nonparametric resampling methods to enhance noise and statistical characteristics in PET imaging.
Career Highlights
Sang Keun Woo currently works at the Korea Institute of Radiological and Medical Sciences, where he continues to push the boundaries of medical technology. His work showcases a blend of engineering and healthcare, reflecting his commitment to improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, Sang Keun Woo has collaborated with notable colleagues such as Sang Moo Lim and Kyeong Min Kim. These partnerships have further enriched the development of advanced methodologies and technologies in the field of radiopharmaceutical research.
Conclusion
In summary, Sang Keun Woo stands out as an influential figure in the realm of radiopharmaceutical innovation. His patents signify a leap forward in imaging technology, underscoring the potential of deep learning and data analysis in enhancing medical diagnostics and treatments. With ongoing collaborations and dedication to research, his contributions are poised to make a lasting impact in the medical field.